Clinical trials on medicinal products
Swissmedic
Official Swiss authority context for clinical trials involving medicinal products in Switzerland.
Open sourceBronnen
Verken Adherlo-gidsen voor medicatietrouw, herinneringsapps, slimme pillendozen, zorginstellingen, klinische studies en verzekeraars.
Lees de gids6
Guides
28
Verified sources
6
Evidence topics
Guides
Medicatietrouw
01Een praktische gids over herinneringen, routines, verpakking en gedeelde ondersteuning die patiënten helpt medicatie zoals voorgeschreven in te nemen.
Explore guideMedicatie app
02Vergelijk de functies die een herinneringsapp nuttig maken: schema's, meldingen, innamegeschiedenis, ondersteuning van zorgverleners en privacy.
Explore guideSlimme pillendoos
03Leer welke functies van een slimme pillendoos belangrijk zijn voor ouderen, zorgverleners en families die complexe medicatieroutines beheren.
Explore guideZorginstellingen
04Een gids voor instellingen die medicatieroutines, waarschuwingen, dashboards en medicatietrouwgegevens nodig hebben voor veel bewoners of patiënten.
Explore guideKlinische studies
05Begrijp hoe real-time medicatietrouw-tracking de datakwaliteit, deelnemersondersteuning en protocolsichtbaarheid kan verbeteren.
Explore guideVerzekering
06Ontdek waarom betere medicatietrouw belangrijk kan zijn voor verzekeraars, chronische ziektebeheer, preventie en vermijdbare zorgkosten.
Explore guideSources and evidence registry
Primary references are centralized here so evidence-backed pages can be updated when a source changes or a better one appears.
These sources provide general information about medication adherence and safety. They do not demonstrate clinical outcomes specific to Adherlo and should not replace advice from a qualified healthcare professional. Always consult your doctor or pharmacist before changing prescribed treatment.
Swissmedic
Official Swiss authority context for clinical trials involving medicinal products in Switzerland.
Open sourceUniversity of Basel
Swiss secondary analysis comparing pharmacy dispensing with electronic monitoring in a small anticoagulant study population; useful for measurement context, not population-wide conclusions.
Open sourceUniversity of Geneva and University of Lausanne
Swiss university evaluation of medication-adherence apps and patient search terms. Its small sample and 2021 app market limit current product comparisons, and it calls for long-term clinical studies.
Open sourceUniversity of Basel / JMIR mHealth and uHealth
Swiss mixed-methods study of nine freely available adherence apps. It found that app outputs only partly matched user needs and supports apps as complements to professional care, not replacements.
Open sourceHelsana
Swiss medication-cost and dispensing context. The report does not measure Adherlo outcomes or establish that reminders reduce costs.
Open sourceUniversity of Geneva and University of Lausanne
Peer-reviewed description of a Swiss university-community-pharmacy program combining patient interviews, electronic monitoring, and interprofessional feedback.
Open sourceUniversity of Geneva and University of Lausanne
Longitudinal Swiss analysis using electronic-container openings as an implementation proxy in 118 supported patients; the records do not confirm ingestion and are not nationally representative.
Open sourceFederal Office of Public Health
Official overview of Swiss therapeutic-products policy, safety, quality, supply, and medical-device regulation.
Open sourceFederal Office of Public Health
Official Swiss reimbursement context for means and devices. Inclusion does not imply that Adherlo is reimbursed.
Open sourceFederal Office of Public Health
Official Swiss program context for prioritizing medication safety and reducing medication-management errors.
Open sourceFederal Office of Public Health
Official Swiss cost-sharing context for affordability discussions; it is not evidence that a specific adherence product reduces insurance spending.
Open sourceFederal Office of Public Health
Official 2025 Swiss policy proposal covering electronic prescriptions and medication plans; implementation details may change during the legislative process.
Open sourceEuropean Medicines Agency
Official description of CTIS and its role in EU and EEA trial authorization, oversight, and public transparency.
Open sourceEuropean Medicines Agency
Official EU and EEA regulatory context for clinical-trial authorization and sponsor obligations; not evidence of product effectiveness.
Open sourceNational Institute for Health and Care Excellence
Clinical guideline supporting patient involvement, practical problem-solving, and non-judgmental adherence conversations.
Open sourceBritish Journal of Clinical Pharmacology
Peer-reviewed taxonomy defining initiation, implementation, and discontinuation to make adherence terminology more precise.
Open sourceInternational Journal of Nursing Studies Advances
Mixed-method systematic review of caregiver challenges and strategies; it highlights varied practices and does not validate one universal workflow.
Open sourceBMJ Open
Systematic review and meta-analysis of randomized trials finding possible benefits while calling for larger and longer studies.
Open sourceJournal of Managed Care & Specialty Pharmacy
Systematic review and meta-analysis of app interventions in chronic disease; results were promising but evidence quality and study duration limit certainty.
Open sourceAge and Ageing
Systematic review reporting mixed evidence: some clinical benefits, limited cost evidence, and a need for more high-quality research.
Open sourceAnnals of Internal Medicine
Peer-reviewed reporting guideline for consistent medication-adherence concepts, measurement, analysis, and reporting.
Open sourceBritish Journal of Clinical Pharmacology
Peer-reviewed discussion of adherence measurement, analysis, and interpretation in clinical trials; not evidence for a specific monitoring product.
Open sourceJournal of Medical Internet Research
Scoping review comparing hardware and software features across smart adherence products; it catalogs products rather than proving clinical outcomes.
Open sourceProceedings of the Human Factors and Ergonomics Society
Peer-reviewed usability evaluation identifying navigation, visibility, and transparency challenges in reminder apps for older adults.
Open sourceWorld Health Organization
Technical report on appropriate polypharmacy, medication review, shared records, and collaboration with patients and caregivers.
Open sourceWorld Health Organization
Technical report on medication discrepancies during care transitions, information quality, patient involvement, and measurement.
Open sourceWorld Health Organization
Foundational global reference describing adherence as a multi-factor process rather than a single patient behavior.
Open sourceWorld Health Organization
Global medication-safety context for preventable harm and safer systems; not an Adherlo outcome claim.
Open source